This topic contains a solution. Click here to go to the answer

Author Question: A cardiovascular clinical nurse specialist describes the dysfunctional endothelium in relation to ... (Read 30 times)

DelorasTo

  • Hero Member
  • *****
  • Posts: 548
A cardiovascular clinical nurse specialist describes the dysfunctional endothelium in relation to cardiovascular disease. What is the major factor in the development of the dysfunctional endothelium?
 
  A) Inflammation
  B) Septicemia
  C) Tumor
  D) Atherosclerosis

Question 2

What is the rationale for not administering tetracycline (Sumycin) in children under the age of 8 years?
 
  A) It will not treat the infection.
  B) It will increase the risk of heart failure.
  C) It will interfere with enamel development.
  D) It will increase the risk for future infections.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

owenfalvey

  • Sr. Member
  • ****
  • Posts: 337
Answer to Question 1

D

Answer to Question 2

C




DelorasTo

  • Member
  • Posts: 548
Reply 2 on: Jul 23, 2018
Gracias!


Perkypinki

  • Member
  • Posts: 339
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Asthma-like symptoms were first recorded about 3,500 years ago in Egypt. The first manuscript specifically written about asthma was in the year 1190, describing a condition characterized by sudden breathlessness. The treatments listed in this manuscript include chicken soup, herbs, and sexual abstinence.

Did you know?

Drying your hands with a paper towel will reduce the bacterial count on your hands by 45–60%.

Did you know?

About 3.2 billion people, nearly half the world population, are at risk for malaria. In 2015, there are about 214 million malaria cases and an estimated 438,000 malaria deaths.

Did you know?

In 2012, nearly 24 milliion Americans, aged 12 and older, had abused an illicit drug, according to the National Institute on Drug Abuse (NIDA).

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library